Zehra Edis

Dr. Zehra Edis

Ajman University, Ajman, United Arab Emirates
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Zehra EdisZehra Edis
Zehra Edis
JWJunli Wang
Junli Wang
MWMuhammad Khurram Waqas
Muhammad Khurram Waqas
MIMunaza Ijaz
Munaza Ijaz
MIMunazza Ijaz
Munazza Ijaz
Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased drug content levels to the targeted spots. Several nano-drug delivery systems designed for tumor-targeting are evaluated in preclinical and clinical trials and showed promising outcomes in cancerous tumors’ clinical management. This review describes nanocarrier’s importance in managing different types of cancers and emphasizing nanocarriers for drug delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers-based delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, magnetic nanoparticles, solid lipid nanoparticles, and quantum dots (QDs). The nanocarrier-based composites are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented.

10 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Majid SharifiMajid Sharifi
Majid Sharifi
William C. ChoWilliam C. Cho
William C. Cho
AAAsal Ansariesfahani
Asal Ansariesfahani
RTRahil Tarharoudi
Rahil Tarharoudi
HMHedyeh Malekisarvar
Hedyeh Malekisarvar
MFMojtaba Falahati
Mojtaba Falahati
The enhanced permeability and retention (EPR) effect in cancer treatment is one of the key mechanisms that enables drug accumulation at the tumor site. However, despite a plethora of virus/inorganic/organic-based nanocarriers designed to rely on the EPR effect to effectively target tumors, most have failed in the clinic. It seems that the non-compliance of research activities with clinical trials, goals unrelated to the EPR effect, and lack of awareness of the impact of solid tumor structure and interactions on the performance of drug nanocarriers have intensified this dissatisfaction. As such, the asymmetric growth and structural complexity of solid tumors, physicochemical properties of drug nanocarriers, EPR analytical combination tools, and EPR description goals should be considered to improve EPR-based cancer therapeutics. This review provides valuable insights into the limitations of the EPR effect in therapeutic efficacy and reports crucial perspectives on how the EPR effect can be modulated to improve the therapeutic effects of nanomedicine.

9 December 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
Zubair AhmadZubair Ahmad
Zubair Ahmad
ARAbdur Rauf
Abdur Rauf
IOIlkay Erdogan Orhan
Ilkay Erdogan Orhan
MMMohammad S. Mubarak
Mohammad S. Mubarak
ZAZuneera Akram
Zuneera Akram
Muthu ThiruvengadamMuthu Thiruvengadam
Muthu Thiruvengadam
Polyphenolic compounds, which are abundant phenolic metabolites in plants, have attracted significant attention because of their diverse biological activities and robust antioxidant properties. This review uniquely describes the extraction characterization, and application pipeline for polyphenols, emphasizing their mechanistic antioxidant actions and translational challenges. Between 1979 and 2025, approximately 141 relevant studies were critically examined, covering the sources, extraction and purification methods, structural diversity, and biological implications of polyphenols. Special attention is given to bioavailability, dose‐dependent effects, and subclass‐specific activities. Various extraction techniques, including solvent extraction, supercritical fluid extraction, and solid‐phase extraction, have been evaluated along with advanced characterization approaches such as spectroscopy and chromatography. The antioxidant mechanisms of polyphenols, ranging from radical scavenging and metal chelation to modulation of signaling pathways, are described, along with their broad applications in nutrition, medicine, and industry. This focused synthesis highlights not only the current state of knowledge, but also identifies key research gaps in clinical validation, formulation strategies, and industrial adoption, providing a forward‐looking perspective for future polyphenol research.

4 August 2019 in Processes
Verified
Journal Article
Open access
PDF file
MRMay Reda
May Reda
Akram AshamesAkram Ashames
Akram Ashames
Zehra EdisZehra Edis
Zehra Edis
Samir Haj BloukhSamir Haj Bloukh
Samir Haj Bloukh
RBRichie Bhandare
Richie Bhandare
HSHamed Sami Abu Sara
Hamed Sami Abu Sara
Nano-sized metals have been introduced as a promising solution for microbial resistance to antimicrobial agents. Silver nanoparticles (AgNPs) have been proven to possess good antimicrobial activity. Green synthesis of AgNPs has been reported as safe, low cost and ecofriendly. This methodology uses extracts originating from different plants to reduce silver ions from AgNO3 into nano-sized particles. In this study, extracts of several plants including ginger, garlic, capsicum and their mixtures were successfully used to produce AgNPs. Numerous spectroscopic, light scattering and microscopic techniques were employed to characterize the synthesized AgNPs. Agar well diffusion assay was performed to investigate the antimicrobial activity of AgNPs. The biosynthesized AgNPs have spherical shape with a size range of 20–70 nm. Garlic extract, pure or in mixture with ginger extract, generated AgNPs of the smallest size. The presence of the plant-origin capping agents surrounding AgNPs was proven by Fourier-transform infrared spectroscopy. The AgNPs, at a concentration of 50 µg/mL, demonstrated potent antimicrobial activity against Staphyloccocus aureus, Escherichia coli and Candida albicans as indicated by the zones of inhibitions. Our results revealed that AgNPs having potent antimicrobial activity could be prepared using different pure plant extracts and their mixtures.

7 June 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
SKSuliman Khan
Suliman Khan
Majid SharifiMajid Sharifi
Majid Sharifi
JGJason P. Gleghorn
Jason P. Gleghorn
MBMohammad Mahdi Nejadi Babadaei
Mohammad Mahdi Nejadi Babadaei
SBSamir Haj Bloukh
Samir Haj Bloukh
William C. ChoWilliam C. Cho
William C. Cho

1 February 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SKSuliman Khan
Suliman Khan
AHArif Hussain
Arif Hussain
FAFarnoosh Attar
Farnoosh Attar
SBSamir Haj Bloukh
Samir Haj Bloukh
Zehra EdisZehra Edis
Zehra Edis
MFMojtaba Falahati
Mojtaba Falahati
Despite the promising medicinal properties, berberine (BBR), due to its relatively poor solubility in plasma, low bio-stability and limited bioavailability is not used broadly in clinical stages. Due to these drawbacks, drug delivery systems (DDSs) based on nanoscale natural polysaccharides, are applied to address these concerns. Natural polymers are biodegradable, non-immunogenic, biocompatible, and non-toxic agents that are capable of trapping large amounts of hydrophobic compounds in relatively small volumes. The use of nanoscale natural polysaccharide improves the stability and pharmacokinetics of the small molecules and, consequently, increases the therapeutic effects and reduces the side effects of the small molecules. Therefore, this paper presents an overview of the different methods used for increasing the BBR solubility and bioavailability. Afterwards, the pharmacodynamic and pharmacokinetic of BBR nanostructures were discussed followed by the introduction of natural polysaccharides of plant (cyclodextrines, glucomannan), the shells of crustaceans (chitosan), and the cell wall of brown marine algae (alginate)-based origins used to improve the dissolution rate of poorly soluble BBR and their anticancer and antibacterial properties. Finally, the anticancer and antibacterial mechanisms of free BBR and BBR nanostructures were surveyed. In conclusion, this review may pave the way for providing some useful data in the development of BBR-based platforms for clinical applications.